Company attributes
Industry
B2X
0
AngelList URL
Pitchbook URL
Legal Name
Idera Pharmaceuticals, Inc.0
Number of Employees (Ranges)
11 – 50
Email Address
clinicaltrials@iderapharma.com
bd@iderapharma.com
ir@iderapharma.com
Phone Number
+148434816000
Full Address
505 Eagleview Boulevard Suite 212 Exton, PA 19341, USA
CIK Number
Place of Incorporation
Investors
DUNS Number
6186556090
IRS Number
43,072,2980
Founded Date
1989
0Total Funding Amount (USD)
4,300,000
Latest Funding Round Date
January 19, 2010
Stock Symbol
IDRA0
Exchange
Board of Directors
CAGE Code
8LUK40
Patents Assigned (Count)
72
Wellfound ID
Country
Other attributes
Company Operating Status
Active
Previous Name
HYBRIDON INC0
SIC Code
2,8360
Ticker Symbol
IDRA
Idera is a clinical-stage biotechnology company focused on taking the next step in immuno-oncology therapies. It designed and are developing tilsotolimod, an investigational Toll-like receptor 9 agonist, for the treatment of advanced solid tumors.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
